Cepheid is a leading molecular diagnostics company dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company’s GeneXpert® system and Xpert® tests deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Cepheid's broad testing portfolio includes respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, nosocomial infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they're needed most - from central laboratories and hospitals to point-of-care facilities.
For more information, visit www.cepheid.com.